Expertise in
12
conditions

Bruno I. Levy

Inria Nancy Grand Est, 
Villers-en-arthies, FR 
Expertise in
12
conditions
Inria Nancy Grand Est, 
Villers-en-arthies, FR 

Overview

Bruno Levy practices practicing medicine in Villers-en-arthies, France.

Mr. Levy is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Heart Attack, Sepsis, Acute Respiratory Distress Syndrome (ARDS), and Heart Transplant.

He is actively involved in clinical research, co-authoring 234 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Inria Nancy Grand Est, Villers-en-arthies, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Enrollment Status: Completed
Publish Date: March 19, 2026
Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial
Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: February 09, 2026
Intervention Type: Procedure
Study Phase: Phase 3
Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
Evaluation of Prone Position in Conscious Patients on Nasal High-flow Oxygen Therapy for COVID-19 Disease Induced Acute Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: December 22, 2025
Intervention Type: Other
Study Phase: Not Applicable
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Drug
Study Drug: Dobutamine
Study Phase: Phase 3
Efficacy of Infusions of Mesenchymal Stem Cells From Wharton Jelly in the Moderate to Severe SARS-Cov-2 Related Acute Respiratory Distress Syndrome (COVID-19): A Phase IIa Double-blind Randomized Controlled Trial
Efficacy of Infusions of Mesenchymal Stem Cells From Wharton Jelly in the Moderate to Severe SARS-Cov-2 Related Acute Respiratory Distress Syndrome (COVID-19): A Phase IIa Double-blind Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: November 05, 2021
Intervention Type: Biological
Study Phase: Phase 2
Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)
Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)
Enrollment Status: Completed
Publish Date: May 07, 2021
Intervention Type: Other
Study Phase: Not Applicable
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Enrollment Status: Completed
Publish Date: March 23, 2020
Intervention Type: Other, Biological
Study Phase: Phase 2
View 6 Less Clinical Trials

234 Total Publications

Pharmacological treatment of cardiogenic shock.
Pharmacological treatment of cardiogenic shock.
Journal: Current opinion in critical care
Published: June 11, 2026

Frequently Asked Questions about Bruno I. Levy

Is Bruno I. Levy a top-rated expert for Cardiogenic Shock?

MediFind is an objective health platform that identifies experts based on real-world data. Bruno I. Levy is classified as an Elite expert for Cardiogenic Shock, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bruno I. Levy participate in research or clinical trials?

Yes. Bruno I. Levy has published 234 articles and abstracts on conditions like Cardiogenic Shock. You can view a list of Bruno I. Levy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Levy's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile